These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 9718855

  • 1. Anti-HBV vaccination before therapy with interferon (IFN) in chronic B hepatitis.
    Fruttaldo L, Schettino G, Mongiò F.
    Eur Rev Med Pharmacol Sci; 1997; 1(6):197-201. PubMed ID: 9718855
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO, Herzog-Hauff S, Schlaak J, Meyer zum Büschenfeld KH, Löhr HF.
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 Jan; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
    Das HS, Sawant P, Shirhatti RG, Vyas K, Vispute S, Dhadphale S, Patrawalla V, Desai N.
    Trop Gastroenterol; 2002 Jan; 23(3):120-1. PubMed ID: 12693152
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W, Muszyńska M, Pawłowska M.
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [Abstract] [Full Text] [Related]

  • 12. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, Furutani M, Yamasaki T, Korenaga K, Yamashita S, Konishi T, Okita K.
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [Abstract] [Full Text] [Related]

  • 13. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 14. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM, Liu CL, Chan SC, Lau GK, Fan ST.
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [Abstract] [Full Text] [Related]

  • 15. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R, Smetana J, Sindelár R, Cecetková B, Prymula R, Kohl I.
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [Abstract] [Full Text] [Related]

  • 16. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A, Gajda M, Pituch-Noworolska A, Drozdz M, Kraśniak A, Kaczmarczyk I, Hołyś S, Zurowski J, Sydor A, Sułowicz W.
    Przegl Lek; 2007 Aug; 64(7-8):470-5. PubMed ID: 18409347
    [Abstract] [Full Text] [Related]

  • 17. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.
    Antivir Ther; 2005 Aug; 10(1):125-33. PubMed ID: 15751770
    [Abstract] [Full Text] [Related]

  • 18. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P, Leroux-Roels G, Law B, Diaz-Mitoma F, Desombere I, Collard F, Tornieporth N, Van Herck K.
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B, Jilg W, Buchholz L, Stremmel W, Engler S.
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH, Deng X, Chen XC, Zhou BP.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.